It has been reported that SEPT4 gene expression is decreased in up to 11 tumor types, including central nervous system tumors, breast cancer, cervical cancer, liver cancer, lung cancer, and melanoma. This evidence concerns the gene SEPTIN4 and lung carcinoma.